Vertex Pharmaceuticals, Inc. (VRTX)
535.17
+10.65
(+2.03%)
USD |
NASDAQ |
Oct 22, 16:00
533.53
-1.64
(-0.31%)
After-Hours: 07:36
Vertex Pharmaceuticals Total Return Price : 535.17 for Oct. 22, 2026
Total Return Price Chart
Historical Total Return Price Data
| Date | Value |
|---|---|
| October 22, 2026 | 535.17 |
| October 21, 2026 | 524.52 |
| October 20, 2026 | 514.65 |
| October 19, 2026 | 501.95 |
| October 16, 2026 | 499.74 |
| October 15, 2026 | 508.75 |
| October 14, 2026 | 498.50 |
| October 13, 2026 | 485.22 |
| October 12, 2026 | 507.00 |
| October 09, 2026 | 510.08 |
| October 08, 2026 | 503.25 |
| October 07, 2026 | 505.64 |
| October 06, 2026 | 502.31 |
| October 05, 2026 | 503.50 |
| October 02, 2026 | 504.73 |
| October 01, 2026 | 506.74 |
| September 30, 2026 | 522.81 |
| September 29, 2026 | 526.73 |
| September 28, 2026 | 527.67 |
| September 25, 2026 | 526.19 |
| September 24, 2026 | 522.38 |
| September 23, 2026 | 516.34 |
| September 22, 2026 | 514.99 |
| September 21, 2026 | 510.72 |
| September 18, 2026 | 508.34 |
| Date | Value |
|---|---|
| September 17, 2026 | 516.34 |
| September 16, 2026 | 513.26 |
| September 15, 2026 | 514.63 |
| September 14, 2026 | 519.51 |
| September 11, 2026 | 515.44 |
| September 10, 2026 | 514.56 |
| September 09, 2026 | 521.12 |
| September 08, 2026 | 528.90 |
| September 04, 2026 | 546.12 |
| September 03, 2026 | 557.96 |
| September 02, 2026 | 556.75 |
| September 01, 2026 | 547.65 |
| August 31, 2026 | 544.52 |
| August 28, 2026 | 541.69 |
| August 27, 2026 | 547.55 |
| August 26, 2026 | 547.29 |
| August 25, 2026 | 552.85 |
| August 24, 2026 | 547.59 |
| August 21, 2026 | 548.05 |
| August 20, 2026 | 540.26 |
| August 19, 2026 | 552.06 |
| August 18, 2026 | 528.19 |
| August 17, 2026 | 515.55 |
| August 14, 2026 | 505.75 |
| August 13, 2026 | 516.44 |
Total Return Price Definition
The total return price allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions.
Total Return Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Price Benchmarks
| Sionna Therapeutics, Inc. | 3.80 |
| Gilead Sciences, Inc. | 157.19 |
| Regeneron Pharmaceuticals, Inc. | 819.09 |
| Alnylam Pharmaceuticals, Inc. | 227.28 |
| Amgen, Inc. | 447.28 |